-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Vitro Biopharma, Inc. quarterly/annual Depreciation history and change rate from 2011 to Q2 2025.
- Vitro Biopharma, Inc. Depreciation for the quarter ending 31 Jul 2025 was $21.6K, a 55.4% decline year-over-year.
- Vitro Biopharma, Inc. Depreciation for the twelve months ending 31 Jul 2025 was $124K, a 29.1% decline year-over-year.
- Vitro Biopharma, Inc. annual Depreciation for 2024 was $181K, a 18.2% increase from 2023.
- Vitro Biopharma, Inc. annual Depreciation for 2023 was $153K, a 6.58% decline from 2022.
- Vitro Biopharma, Inc. annual Depreciation for 2022 was $164K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)